Contraception
📧 Sign up to get email alerts when something new happens for Contraception.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-05-08FDA Approved: LO LOESTRIN FE — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for LO LOESTRIN FE by Allergan, Inc., extending the product's labeling/approval as a combined or…
-
FDA approval · 2013-03-29FDA Approved: ALYACEN 1/35 — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for ALYACEN 1/35 (norethindrone and ethinyl estradiol) from Glenmark Pharmaceuticals Inc., USA, auth…
-
FDA label_change · 2013-02-27FDA Approved: LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for a levonorgestrel and ethinyl estradiol combination contraceptive, updating …
-
FDA approval · 2013-01-31FDA Approved: SPRINTEC — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for SPRINTEC, a combination oral contraceptive containing norgestimate and ethinyl estradiol, from T…
-
FDA approval · 2013-01-31FDA Approved: LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals, Inc.'s supplemental application for a combination oral contraceptive containing levonorgestrel and ethin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-01-30FDA Approved: NORGESTIMATE AND ETHINYL ESTRADIOL — Original Application (AvKARE)
FDA approves AvKARE's generic oral contraceptive combination of norgestimate and ethinyl estradiol through an original ANDA submission.
-
FDA approval · 2013-01-18FDA Approved: LEVONORGESTREL AND ETHINYL ESTRADIOL — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic oral contraceptive combination levonorgestrel and ethinyl estradiol under an Original Applicatio…
-
CLINICAL_TRIALS trial_result · 2012-10-18Clinical Trial Update: Maintaining Intrauterine Devices (IUDs) in Teens (MINT): A Randomization Trial [Phase 4]
A Phase 4 randomized trial evaluating maintaining intrauterine devices (IUDs) in teens, completed with results posted in 2012.
-
FDA approval · 2012-10-17FDA Approved: KURVELO — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Kurvelo, a generic combination oral contraceptive containing levonorgestrel and ethinyl estradiol, under an original ANDA from …
-
FDA approval · 2012-09-19FDA Approved: LORYNA — Supplemental Application (Xiromed, LLC.)
FDA approved a supplemental application for LORYNA (DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS) from Xiromed, LLC.
-
FDA approval · 2012-07-31FDA Approved: ALYACEN 1/35 — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for ALYACEN 1/35, a generic combined oral contraceptive containing norethindrone and ethinyl estradi…
-
FDA approval · 2012-06-28FDA Approved: NORGESTIMATE AND ETHINYL ESTRADIOL — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approves a supplemental application for Norgestimate and Ethinyl Estradiol from Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2012-06-25FDA Approved: TRI-LO-MARZIA — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' Tri-Lo-Marzia as an original-application generic oral contraceptive containing norgestimate and ethinyl …
-
FDA approval · 2012-05-30FDA Approved: TRI-LINYAH — Original Application (Northstar Rx LLC)
FDA approved TRI-LINYAH, a generic combined oral contraceptive containing norgestimate and ethinyl estradiol, under an original application …
-
FDA approval · 2012-05-23FDA Approved: MONO-LINYAH — Original Application (Northstar Rx LLC)
FDA approved MONO-LINYAH (norgestimate and ethinyl estradiol) from Northstar Rx LLC under an original application, a combined oral contracep…
-
FDA approval · 2012-04-05FDA Approved: NORGESTIMATE AND ETHINYL ESTRADIOL — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved the original application for NORGESTIMATE AND ETHINYL ESTRADIOL, a generic oral contraceptive from Glenmark Pharmaceuticals Inc…
-
FDA approval · 2012-03-27FDA Approved: WERA — Original Application (Northstar Rx LLC)
FDA approved the original application for WERA, a generic norethindrone/ethinyl estradiol oral contraceptive manufactured by Northstar Rx LL…
-
FDA approval · 2012-02-13FDA Approved: SAFYRAL — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved a supplemental application for SAFYRAL (drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium) filed by …
-
FDA approval · 2011-12-22FDA Approved: DASETTA 7/7/7 — Original Application (Northstar Rx LLC)
FDA approved the generic product DASETTA 7/7/7 containing norethindrone and ethinyl estradiol under ANDA090946 by Northstar Rx LLC. The prod…
-
CLINICAL_TRIALS trial_result · 2011-10-31Clinical Trial Update: A Multicenter Trial to Evaluate the Insertion Characteristics of the Radiopaque Etonogestrel Implant Using a Next Generation Applicator (34530)(P05702) [Phase 3]
A multicenter Phase 3 trial evaluating insertion characteristics of a radiopaque etonogestrel implant using a next-generation applicator has…
-
CLINICAL_TRIALS trial_result · 2011-08-30Clinical Trial Update: Effects on Hemostasis, Lipids, Carbohydrate Metabolism, Adrenal & Thyroid Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG-EE (292004)(COMPLETED)(P05764) [Phase 3]
Phase 3 trial comparing NOMAC-E2 combined oral contraceptive to LNG-EE, evaluating effects on hemostasis, lipids, carbohydrate metabolism, a…
-
CLINICAL_TRIALS trial_result · 2011-08-29Clinical Trial Update: Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722) [Phase 3]
Phase 3 trial comparing NOMAC-E2 with a DRSP/EE combined oral contraceptive; completed with posted results in 2011 evaluating efficacy and s…
-
CLINICAL_TRIALS trial_result · 2011-08-29Clinical Trial Update: Efficacy and Safety of the Combined Oral Contraceptive (COC) NOMAC-E2 Compared to a COC Containing DRSP/EE (292001)(COMPLETED)(P05724) [Phase 3]
A Phase 3 trial comparing NOMAC-E2 to a standard combined oral contraceptive with DRSP/EE has completed with results posted in 2011, focusin…
-
CLINICAL_TRIALS trial_result · 2011-08-29Clinical Trial Update: Effects on Bone Mineral Density (BMD) of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG/EE (292005)(P05765)(COMPLETED) [Phase 3]
A Phase 3 completed trial comparing NOMAC-E2 combined oral contraceptive to LNG/EE in terms of effects on bone mineral density.
-
CLINICAL_TRIALS trial_result · 2011-08-29Clinical Trial Update: Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723) [Phase 3]
A Phase 3 completed trial comparing NOMAC-E2 combined oral contraceptive with a DRSP/EE-containing COC evaluating effects on ovarian functio…